Lihteh Wu. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Anti-Inflammatory Agents/administration & dosageAntibodies, Monoclonal/administration & dosageDiabetic Retinopathy/drug therapyFemaleHumansMacular Edema/drug therapyMaleTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances: See more » Anti-Inflammatory AgentsAntibodies, MonoclonalTumor Necrosis Factor-alpha
Year: 2013 PMID: 23624521 DOI: 10.1097/IAE.0b013e31828bcb2f
Source DB: PubMed Journal: Retina ISSN: 0275-004X Impact factor: 4.256